Información del producto
- 4,8-Methano-8aH-bisbenzofuro[3,2-e:2′,3′-g]isoquinoline-1,8a-diol, 7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, (4bS,8R,8aS,14bR)-, methanesulfonate (salt)
- 4,8-Methano-8aH-bisbenzofuro[3,2-e:2′,3′-g]isoquinoline-1,8a-diol, 7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, [8R-(4bS*,8α,8aβ,14bβ)]-, methanesulfonate (salt)
- Naltriben methanesulfonate (salt)
- 4,8-Methano-8aH-bisbenzofuro[3,2-e:2′,3′-g]isoquinoline-1,8a-diol, 7-(cyclopropylmethyl)-5,6,7,8,9,14b-hexahydro-, (4bS,8R,8aS,14bR)-, methanesulfonate (1:1)
Naltriben mesylate is a pharmacological agent that has been shown to inhibit the binding of δ-opioid receptor agonists to their receptors, and thus blocks the effects of these drugs. It also inhibits the production of δ-opioid receptor heteromers, which are complexes consisting of a δ-opioid receptor and a kappa-opioid receptor. Naltriben mesylate is being studied for its use in the treatment of bone cancer. In addition, Naltriben mesylate has been shown to block the binding of δ-opioid receptor agonists to their receptors in functional assays, as well as in studies using electrospray ionization quadrupole time-of-flight mass spectrometry (ESI QToF).
Propiedades químicas
Consulta técnica sobre: 3D-FN170890 Naltriben mesylate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.